News and Comments

ADVENTRIX (ANX): A REVERSE SPLIT WITH SOME EXCITING NEWS.

  Wednesday, April 28, 2010

Despite the emergence of new biological treatments for cancer, Chemotherapy is still essential, and indispensable as a major treatment for malignancies. The adverse events caused by these chemicals were found to be acceptable as a risk versus the great reward of using chemotherapy. The technological evolution that took place in the past decade and the surfacing of state-of-the-art technologies such as nanotechnology, scientists believed possibilities exist now for improving the adverse effect profiles of these therapeutic molecules. Reformulating the existing products has become an increasingly common product lifecycle-management technique. We read that a 2004 report on the U.S. drug market from BCC, Inc. projected that reformulations would grow from 62% of the market in 2003 to 79% in 2008. Finding ways to modify and improve existing products’ side effect profiles has become feasible after being essential but unreachable goal.  More...


Recent Postings


Archive


Tags

Ridaforolimus ARCA (ABIO) NEUROCRINE (NBIX) Intercept (ICPT) Xoma (XOMA) Pluristem (PSTI) Idenix (IDIX) CEMPRA (CEMP) Agenus (AGEN) NEKTAR (NKTR)) Exelixis (EXEL) Alder Biopharmaceuticals (ALDR) Abbott Laboratories (ABT) galapagos (GLPG) IDERA (IDRA) Bellicum (BLCM) ARGOS (ARGS) Cytokinetics (CYTK) Elan (ELN) RenenxBio (RGNX) Velcade (bortezomib) KERYX (KERX) JOUNCE THERAPEUTICS (JNCE) CRISPR Therapeutics (CRSP) Roche (ROCHE) Sequenom (SQNM) Mirati Therapeutics (MRTX) Revlimid (lenolidamide) Roche (RHHBY) Inovio (INO) Valeant Pharmaceuticals International (VRX) Ocular Therapeutix (OCUL) CompuGen (CGEN) VANDA (VNDA) Auspex (ASPX) AERIE PHARMACEUTICALS Multiple Myeloma Micromet (MITI) PTC Therapeutics (PTCT) AstraZeneca (AZN) OncoCyte (OCX) Anadys (ANDS) Spike Therapeutics (ONCE) LEXICON (LXRX) Sanofi-Aventis (SAN) Dendreon (DNDN) C4 Therapeutics AGOS (ARGS) Sanofi (SNA) Prolor Biotech (PBTH) Intermune (ITMN) Theravance Bio Pharma (TBPH) JUNO (JUNO) Prosensa (RNA) Aimmune Therapeutics (AIMT) ADVENTRIX (ANX) Zerenex MODERNA Amgen (AMGN) Alnylam (ALNY) SUNESIS PHARMACEUTICALS (SNSS) Endometrial Cancer Trastuzumab-DM1 Gilead (GILD) Adaptimmune (ADAP) ZALTRAP™ GUARDIAN HEALTH Advaxis (ADXS) GlaxoSmithKline (GSK) Vertex (VRTX) Telaprevir Regeneron (REGN) Ariad (ARIA) Genentech Agenus (AGEN Human Longevity (HLI) Intrexon (XON) Incyte (INCY) ImmunoGen (IMGN) OSI (OSIP) Benlysta (belimumab) INNOVIVA (INVA) SYNTA (SNTA) Galena (GALE) Merck (MRK) Editas (EDIT) Biocryst (BCRX) Global Cell Therapeutics (GBT) Sarepta (SRPT) TOKAI (TKAOI) Ziofpharm (ZIOP) Tysabri Jazz Pharmaceuticals (JAZZ) NANTKWEST (NK) PORTOLA (PTLA) KITE (KITE) SERES THERAPEUTICS (MCRB) Rapamune Seattle Genetics (SGEN) REGULUS (RGLS) Bristol-Myers Squibb (BMY) BIOMARIN (BMRN) ACADIA (ACAD) Human Genome Sciences (HGSI) Illumina (ILMN) HALOZYME (HALO) ABBVIE (ABBV) Herceptin ISIS (ISIS) NOVOCURE (NVCR) Sanofi (SNY) Ionis (IONS) Biogen Idec (BIIB) Theravance (THRX) Sangamo (SGMO) Vitae Pharmaceuticals (VTAE) Dynavax (DVAX) Anacor (ANAC) Onyx (ONXX) Array Pharmaceuticals (ARRY)